2022 Targeted Therapies of Lung Cancer Meeting (TTLC) - Slides
Conference | English
Image For Activity Cover
Availability
On-Demand
13 Courses
Cost
$0.00
Credit Offered
No Credit Offered
This longstanding highly interactive meeting will feature novel research on emerging combination immunotherapy approaches and targets such as KRAS, G12C, and HER2. Relevant topics of effective therapeutic control of resistance to targeted therapies as well as the state of development of antibody-drug conjugates will be included in the program.
Powered By